Literature DB >> 3987554

Electrophysiological effects of felodipine.

M Been, P W Macfarlane, W S Hillis.   

Abstract

Oral felodipine (10mg) was given to 11 patients undergoing routine invasive electrophysiological studies. Systolic blood pressure fell by 31 mm Hg from 130 +/- 17.5 to 99 +/- 10 mm Hg (mean +/- SD, p less than 0.001) while diastolic pressure fell from 78 +/- 9 to 60 +/- 8mm Hg (p less than 0.001), thus confirming its vasodilator properties. Heart increased from 64 +/- 10 to 78 +/- 16 beats/min (p less than 0.001). The A-H interval was significantly prolonged from 97 +/- 14 to 110 +/- 24 msec (p less than 0.01) while there was no change in the H-V interval. Sinus node recovery time showed no change when corrected for heart rate. The effective refractory period of the atrioventricular node was shortened from 317 +/- 38 to 287 +/- 27 msec (p less than 0.01) as was the effective refractory period of the ventricular Purkinje fibres from 251 +/- 18 to 237 +/- 20 msec (p less than 0.005). These haemodynamic and electrophysiological changes suggest that this compound is an effective vasodilator and may have potential antiarrhythmic properties.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3987554     DOI: 10.2165/00003495-198500292-00014

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  13 in total

1.  The effects of cycle length on cardiac refractory periods in man.

Authors:  P Denes; D Wu; R Dhingra; R J Pietras; K M Rosen
Journal:  Circulation       Date:  1974-01       Impact factor: 29.690

2.  Studies on the clinical pharmacology of prazosin. I: Cardiovascular, catecholamine and endocrine changes following a single dose.

Authors:  P C Rubin; T F Blaschke
Journal:  Br J Clin Pharmacol       Date:  1980-07       Impact factor: 4.335

3.  Verapamil in cardiology.

Authors:  D Krikler
Journal:  Eur J Cardiol       Date:  1974-08

4.  Interaction of the antihypertensive drug felodipine with calmodulin.

Authors:  S L Bostróm; B Ljung; S Mårdh; S Forsen; E Thulin
Journal:  Nature       Date:  1981-08-20       Impact factor: 49.962

5.  Effect of nifedipine on atrioventricular conduction as compared with verapamil. Intracardiac electrophysiological study.

Authors:  E Rowland; T Evans; D Krikler
Journal:  Br Heart J       Date:  1979-08

6.  The effect of felodipine on ventricular fibrillation after coronary artery ligation in the anaesthetized pig.

Authors:  P D Verdouw; B H Wolffenbuttel
Journal:  Br J Pharmacol       Date:  1983-05       Impact factor: 8.739

7.  Felodipine--a new vasodilator, in addition to beta-receptor blockade in hypertension.

Authors:  D Elmfeldt; T Hedner
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

8.  Beneficial effect of intravenous diltiazem in the acute management of paroxysmal supraventricular tachyarrhythmias.

Authors:  A Betriu; B R Chaitman; M G Bourassa; G Brévers; J M Scholl; P Bruneau; P Gagné; M Chabot
Journal:  Circulation       Date:  1983-01       Impact factor: 29.690

9.  Hydralazine tachycardia and sympathetic cardiovascular reactivity in normal subjects.

Authors:  H Vidrio; I Tena
Journal:  Clin Pharmacol Ther       Date:  1980-11       Impact factor: 6.875

10.  Haemodynamic effects of a new vasodilator drug, felodipine, in healthy subjects.

Authors:  G Johnsson; G Murray; A Tweddel; I Hutton
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

View more
  8 in total

1.  Acute haemodynamic effects of felodipine in congestive heart failure.

Authors:  H Emanuelsson; A Hjalmarson; S Holmberg; F Waagstein
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 2.  Felodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.

Authors:  E Saltiel; A G Ellrodt; J P Monk; M S Langley
Journal:  Drugs       Date:  1988-10       Impact factor: 9.546

Review 3.  'Second generation' dihydropyridine calcium antagonists. Greater vascular selectivity and some unique applications.

Authors:  D D Freedman; D D Waters
Journal:  Drugs       Date:  1987-11       Impact factor: 9.546

4.  Felodipine ER formulation in the treatment of mild hypertension: efficacy and tolerability vs placebo.

Authors:  A Bossini; C Di Veroli; G Cavallotti; V Cagli
Journal:  Br J Clin Pharmacol       Date:  1990-10       Impact factor: 4.335

5.  Twenty-four hour profile of the hypotensive action of felodipine in essential hypertension.

Authors:  I G Crozier; H Ikram; M G Nicholls; C J Low
Journal:  Cardiovasc Drugs Ther       Date:  1990-04       Impact factor: 3.727

6.  Haemodynamic effects of felodipine in congestive heart failure.

Authors:  P Held; K Swedberg
Journal:  Drugs       Date:  1987       Impact factor: 9.546

7.  Electrophysiological effects of felodipine in combination with metoprolol.

Authors:  C R Jones; A P Rae; M Been; P J de Vane; R R Jamieson; R S Hornung; W S Hillis
Journal:  Drugs       Date:  1985       Impact factor: 9.546

8.  Felodipine in hypertension.

Authors:  P J Mace; T J Stallard; W A Littler
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.